Naobios is a GMP-certified contract development and manufacturing organisation (CDMO) focused on biopharmaceuticals, particularly virus-based products. The company offers a full range of services for developing and manufacturing preclinical and clinical batches of viral vectors, vaccines, oncolytic viruses, and viral challenge agents.

Naobios provides expertise in bioprocess development, including upstream and downstream processing, as well as GMP-compliant biomanufacturing. They support clients with investigational product manufacturing, virus and cell banking, and quality control testing, including stability studies and analytical development. Naobios also works with BSL2 and BSL3 viruses.

Key Products and Services

• Virus-based products (live and inactivated viruses)
• Oncolytic viruses and advanced therapy medicinal products (ATMPs)
• Human viral challenge agents
• Exosomes
• GMP biomanufacturing and investigational product manufacturing
• Bioprocess development (USP and DSP)
• Analytical development and stability studies

Naobios is committed to delivering high-quality services for the growing field of virus-based therapies, ensuring its clients’ success in innovative biopharmaceutical development.